| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |